These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 18684640)

  • 1. Specificity in cancer immunotherapy.
    Schietinger A; Philip M; Schreiber H
    Semin Immunol; 2008 Oct; 20(5):276-85. PubMed ID: 18684640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune based therapies in cancer.
    Krüger C; Greten TF; Korangy F
    Histol Histopathol; 2007 Jun; 22(6):687-96. PubMed ID: 17357098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel era of cancer/testis antigen in cancer immunotherapy.
    Meng X; Sun X; Liu Z; He Y
    Int Immunopharmacol; 2021 Sep; 98():107889. PubMed ID: 34174699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Tumor Antigens and Cancer Immunotherapy.
    Vigneron N
    Biomed Res Int; 2015; 2015():948501. PubMed ID: 26161423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The present status and future prospects of peptide-based cancer vaccines.
    Hirayama M; Nishimura Y
    Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
    Seremet T; Brasseur F; Coulie PG
    Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making the most of mucin: a novel target for tumor immunotherapy.
    Barratt-Boyes SM
    Cancer Immunol Immunother; 1996 Nov; 43(3):142-51. PubMed ID: 9001567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy: new insights].
    Geissler M; Weth R
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2236-46. PubMed ID: 12564040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor vaccine: current trends in antigen specific immunotherapy.
    Baral R
    Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy.
    Sensi M; Anichini A
    Clin Cancer Res; 2006 Sep; 12(17):5023-32. PubMed ID: 16951217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
    Jäger E; Jäger D; Knuth A
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tumor antigen-specific cytotoxic T lymphocytes and cancer immunotherapy - review].
    Liu Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):244-8. PubMed ID: 15157343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cyclins: a family of widely expressed tumor antigens?
    von Bergwelt-Baildon MS; Kondo E; Klein-González N; Wendtner CM
    Expert Rev Vaccines; 2011 Mar; 10(3):389-95. PubMed ID: 21434806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
    Yang P; Meng M; Zhou Q
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor vaccines and beyond.
    Melenhorst JJ; Barrett AJ
    Cytotherapy; 2011 Jan; 13(1):8-18. PubMed ID: 21067312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens.
    Pan RY; Chung WH; Chu MT; Chen SJ; Chen HC; Zheng L; Hung SI
    J Immunol Res; 2018; 2018():4325874. PubMed ID: 30662919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors.
    Leko V; Rosenberg SA
    Cancer Cell; 2020 Oct; 38(4):454-472. PubMed ID: 32822573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Landscape of Tumor Antigens in T Cell Immunotherapy.
    Ilyas S; Yang JC
    J Immunol; 2015 Dec; 195(11):5117-22. PubMed ID: 26589749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
    Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
    J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.